Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12
Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12
批准号:
9042369
负责人:
Harald Junge
金额:
$36.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2019-03-31
关键词:
AffectBindingBiological AssayBiological ModelsBiologyBlindnessBloodBlood VesselsBlood capillariesBypassCellsChimera organismComplexCre-LoxPDefectDevelopmentDimerizationDiseaseDistantEndothelial CellsExudative age-related macular degenerationEye DevelopmentFamilyGenesGeneticGenetic studyGoalsHealthHomoHuman GeneticsImmunoprecipitationIn VitroInheritedIntegral Membrane ProteinInvestigationLeadLigandsLigationLipoprotein ReceptorLuciferasesMediatingMediator of activation proteinMembrane ProteinsModelingMolecularMolecular GeneticsMorphogenesisMuller&aposs cellMusMutant Strains MiceMutationNeuronsNorrie&aposs diseasePathway interactionsPatientsPatternPericytesPhenocopyPhenotypePlayPoint MutationProteinsReporterReportingRetinaRetinalRetinal DiseasesRoleSignal PathwaySignal TransductionSystemTacrolimus Binding ProteinsTestingTherapeutic InterventionVascular DiseasesVascular Endothelial CellVascularizationVisionVisual impairmentbasecapillarycell typein vivoloss of functionmemberneovascularnovelprogramsproliferative diabetic retinopathyreceptorreceptor bindingresearch studyresponseretina blood vessel structureretinal angiogenesisretinal progenitor celltargeted treatmenttrafficking
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our overall objective is to understand retinal angiogenesis in a context of development and ocular disease, using mice as a model system. Retinal vascular diseases, including proliferative diabetic retinopathy and neovascular age related macular degeneration, are major causes of impaired vision and blindness. One of the central angiogenic signaling pathways in the retina is Norrin/Frizzled4 signaling. Norrin signals via its receptor Frizzled4 and the co-receptor LRP5 on vascular endothelial cells to activate ß-catenin signaling and transcriptional programs. The pathway plays a critical role in instructing retinal vascular morphogenesis and blood-retina barrier formation. Impaired Norrin/Frizzled4 signaling causes familial exudative vitreoretinopathy, an inherited disease that can cause blindness. The focus of this application is on the membrane protein TSPAN12, a novel and essential component of Norrin/Frizzled4 signaling. Tspan12 gene disrupted mice phenocopy norrin and frizzled4 mutant mice, and TSPAN12 is a strong facilitator of Norrin/Frizzled4 signaling in cell-based assays. We have three objectives: i) We hypothesize that TSPAN12 is functionally required in retinal endothelial cells and that restricted TSPAN12 expression modulates the spatio-temporal pattern of pathway activation. This model predicts that conditional disruption of the tspan12 gene in endothelial cells, but not in other cell types, recapitulates the loss-of-function phenotypes, e.g., lack of intraretinal capillaries and impaired blood-retina barrier integrity. We will use the Cre-Lox system to test this model. ii) TSPAN12 is required only in Norrin-induced but not in Wnt-induced Frizzled4 signaling. This is an intriguing and unexplained feature of Norrin/Frizzled4 signaling. We hypothesize that Norrin cannot efficiently induce protein interactions in the Norrin receptor complex and therefore operates together with TSPAN12. In contrast, Wnts may induce the required protein interactions autonomously (e.g., Norrin and Wnts differ in their ability to bind receptor and co-receptor simultaneously). We will test this hypothesis by characterizing protein interactions in the Norrin receptor complex, by determining which interactions are promoted by Norrin, Wnt3a, and TSPAN12, and by determining the consequences of abolishing or forcing relevant protein interactions in cell-based reporter assays. iii) Several recent human genetic studies independently reported mutations in tspan12 in patients with familial exudative vitreoretinopathy. We will determine if the reported mutations impair the function of TSPAN12 in Norrin/Frizzled4 signaling. Building on our investigation of TSPAN12 protein interactions, we will ask if one or several of the mutations impair critical protein interactions of TSPAN12. We will also determine if one or several of the mutations impair the folding or trafficking of TSPAN12. Conclusion: Norrin/Frizzled4 signaling is under investigation as a target for therapeutic intervention. A refined mechanistic model of TSPAN12 function in Norrin/Frizzled4 signaling should aid efforts to target this pathway in neovascular diseases of the retina.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Training Program in Translational Vision Sciences
-
批准号:10408879
-
项目类别:
-
资助金额:$14.76万
-
财政年份:2016
-
负责人:Harald Junge
-
依托单位:
Training Program in Translational Vision Sciences
-
批准号:10609517
-
项目类别:
-
资助金额:$15.57万
-
财政年份:2016
-
负责人:Harald Junge
-
依托单位:
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier
-
批准号:10226205
-
项目类别:
-
资助金额:$44.04万
-
财政年份:2014
-
负责人:Harald Junge
-
依托单位:
Norrin/Frizzled4 Signaling in Retinal Angiogenesis: The Role of TSPAN12
-
批准号:8668328
-
项目类别:
-
资助金额:$37.03万
-
财政年份:2014
-
负责人:Harald Junge
-
依托单位:
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier
-
批准号:10475728
-
项目类别:
-
资助金额:$44.04万
-
财政年份:2014
-
负责人:Harald Junge
-
依托单位:
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier
-
批准号:10020983
-
项目类别:
-
资助金额:$45.14万
-
财政年份:2014
-
负责人:Harald Junge
-
依托单位:
Norrin Signaling in the Retina: Regulation of the Blood-Retina Barrier
-
批准号:10676964
-
项目类别:
-
资助金额:$45.41万
-
财政年份:2014
-
负责人:Harald Junge
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: